Form 4: Health Catalyst Executive Kevin Freeman Sells 7,500 Shares
SEC Form 4
Kevin Freeman, Chief Commercial Officer of Health Catalyst, Inc., sold 7,500 shares of common stock at a price of $6.5344 per share on June 11, 2024, according to a Form 4 filing.
Summary
- On June 11, 2024, Kevin Freeman, the Chief Commercial Officer of Health Catalyst, Inc. (HCAT), sold 7,500 shares of the company's common stock.
- The sale was executed at a price of $6.5344 per share.
- Following the transaction, Freeman directly owns 266,153 shares of Health Catalyst common stock.
- The sale was conducted under a pre-arranged trading plan adopted on March 11, 2024, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative prospects for the company.
Industry Context
Insider sales are common and can be for various reasons, including diversification or personal financial planning. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on immediate inside information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 06/11/2024 | Date of the stock sale transaction |
| 06/12/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.